According to the above results in clinical samples, we speculated that Nrf2 high expression inhibited MSH2 expression, caused MMR deficiency and increased the tumor mutation burden, which can induce gene instability-dependent drug resistance. This evidence concerns the gene NFE2L2 and mismatch repair cancer syndrome 1.